Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Cachexia × Pentoxifylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoidosis, Pulmonary 1 Lymphedema 1 HIV Infections 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Cachexia 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Pentoxifylline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000646 2021-11-02

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed

Acquired Immunodeficiency Syndrome, Cachexia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡